Gary Ingenito - 14 Sep 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Medical & Reg. Officer
Signature
/s/ Gary Ingenito
Issuer symbol
CPRX
Transactions as of
14 Sep 2022
Net transactions value
-$1,612,589
Form type
4
Filing time
16 Sep 2022, 17:00:37 UTC
Previous filing
23 Jun 2022
Next filing
08 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $220,550 +55,000 +249% $4.01 77,053 14 Sep 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $860,915 -55,000 -71% $15.65 22,053 14 Sep 2022 Direct F1, F2
transaction CPRX Common stock, par value $0.001 per share Options Exercise $408,320 +88,000 +399% $4.64 110,053 14 Sep 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $1,380,544 -88,000 -80% $15.69 22,053 14 Sep 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -55,000 -5.1% $0.000000 1,016,667 14 Sep 2022 Common Stock 55,000 $4.01 Direct F4
transaction CPRX Options to purchase common stock Options Exercise $0 -88,000 -8.7% $0.000000 928,667 14 Sep 2022 Common Stock 88,000 $4.64 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Dr. Ingenito sold the shares on the open market for personal reasons and not as a result of any disagreement with the Registrant. Dr. Ingenito remains an officer of the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.56 to $15.80 per share.
F3 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.62 to $15.79 per share.
F4 Options vested in three annual tranches beginning on January 2, 2018.
F5 Options vested in two annual tranches beginning on December 2, 2020.